AcuImmune is a comprehensive source of immune assessment testing for research and non-GLP preclinical analysis. The company specializes in customizable immunoassays to identify cancer biomarkers, characterize drug candidate immunogenicity, and aid in allergy diagnosis. AcuImmune has also supported translational studies in gene therapy, cardiovascular and metabolic disorders, inflammation, and oncology. Scientists at AcuImmune offer 20 years of experience in the development of robust immunological assays.
| Website | https://acuimmune.com/ |
| Revenue | $6 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2014 |
| Address | 21818 Craggy View St Ste 203, Chatsworth, California 91311, US |
| Phone | +1 818-772-4494 |
| Fax | (818) 772-4980 |
| Technologies | |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Immunoassay Development, Cancer Biomarkers, Immunological Assays, Therapeutic Antibodies, Immunology Research, Cancer Immunology, Biomarker Discovery, Drug Development Testing, Biomarker Identification, Preclinical Testing, Immunology Services, Clinical Trial Support |
| Competitors | Roche, Novartis, AbbVie, Pfizer, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, Receptos, a wholly-owned subsidiary of Celgene, Lilly India +35 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Acuimmune employee's phone or email?
Acuimmune Questions
The Acuimmune annual revenue was $6 million in 2026.
Acuimmune is based in Chatsworth, California.
The NAICS codes for Acuimmune are [541714, 54, 5417, 54171, 541].
The SIC codes for Acuimmune are [87, 873].
Related Companies
